Treating patients with Vit D and Early Treatment

Dr. Ira Bernstein recommends Vit D, advocates for early treatment, describes multi-drug use for late phase COVID-19, and comments on Ivermectin supply in Canada.

Visit Site

Media, NEW: Early Treatment, NEW: Featured, NEW: Knowledge Base, NEW: Pandemic Management, NEW: Prevention & Treatment, NEW: Self Advocacy
antihistamines, budesonide, Canada Integrative Medicine Association, Chris Martenson, CIMA, colchicine, corticosteroids, COVID, COVID-10, exercise, FLCCC, fluvoxamine, I-MASK, ivermectin, magnesium, nutrition, off-label, quercetin, selenium, vitamin C, vitamin D, weight gain, zinc

The Blind Spot in COVID-19 Vaccination Policies: Under Reported Adverse Events

In this peer-reviewed publication, Dr Patrick Provost examines the post-vaccination adverse events reporting system and the inherent weaknesses that may result in underreporting. Based on

A 6-Week Time Period May not be Sufficient to Identify Potential Adverse Events Following COVID-19 Vaccination

Drs Prevost and Banoun have published a peer-reviewed article advocating for extension of the timeline to accept entries into the adverse event reporting systems for

Canadians Injured by mRNA Vaccines Speak Out

We are honoured to share with you a new CCCA video series in which fellow Canadians share their stories of being injured after receiving the COVID-19 mRNA vaccines

Treating patients with Vit D and Early Treatment

Treating patients with Vit D and Early Treatment

Related Posts

A 6-Week Time Period May not be Sufficient to Identify Potential Adverse Events Following COVID-19 Vaccination

Canadian Covid Care Alliance